Search earnings tickers

MRNA

2024Q4BMO

Moderna Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-02-14 · Fiscal end 2024-12-31 · Features as of 2025-02-13

← Earnings history

Street

Consensus EPS-2.76

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move5.6%

IV front—

P/C full—

P/C front—

Features as of2025-02-13

Run-up

Close—

Ret 5d-5.0%

Ret 10d-22.2%

Ret 20d-8.2%

Ret 30d-18.9%

Print

Actual EPS

-2.91Miss

Estimated EPS-2.76

Actual revenue

956.0M

Surprise %-5.4%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction+8.1%

Implied vs actual

Implied 5.6%Actual 4.4%

Gap reaction-4.4%

Day result+3.4%

Next-day upYes

Realized / IV0.78×

Post tape

Post 5d+2.8%

Post 10d-8.2%

Post volume25.3M

Vol ×10d2.20×

Vol ×20d2.08×

Post range15.3%